This talk will provide an evidence-based approach to the management of osteoporosis. The faculty will cover updates on newly approved osteoporosis medications and recent publications. Treatment duration and current estimates of the rates of adverse effects of therapy will also be reviewed.

Learning Objectives:

  • Select osteoporosis treatment candidates appropriately
  • Identify the risks and benefits of several recently FDA-approved osteoporosis medications
  • Recognize why certain osteoporosis medications are considered first-line therapies
  • Apply recent guidelines regarding osteoporosis treatment duration